Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Breast Neoplasms 2Urologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 4enfortumab vedotin 3Gemcitabine 3Cisplatin 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1testosterone 17 beta-cypionate 1temsirolimus 1galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1dodecyl maltoside 1Valproic Acid 1Testosterone Propionate 1Sunitinib 1Standard of Care 1Sirolimus 1Ringer's acetate 1Radiation Dose Hypofractionation 1Psychiatric Nursing 1Practice Guidelines as Topic 1Physical Therapy Modalities 1Mitomycin 1Methyltestosterone 1Immunoglobulin G 1Fluorouracil 1Etoposide 1Doxycycline 1Disulfides 1Cyclophosphamide 1Cetuximab 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Doxycycline × 90 days × Clear all
NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
18 enrolled
BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡